Comparison of different outcome measures for psoriatic arthritis in patients treated with infliximab or placebo [6]

Annals of the Rheumatic Diseases

Volumn 66, Issue 1, 2007, Pages 138-140

  Vander Cruyssen, B ^a   De Keyser, F ^a   Kruithof, E ^a   Meilants, H ^a   Van Den Bosch, F ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB;

ADULT; AGED; ANKYLOSING SPONDYLITIS; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; LETTER; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; FEMALE; HEALTH STATUS INDICATORS; HUMANS; JOINTS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 33846008694     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2006.055541     Document Type: Letter

References (9)

1. Gladman DD, Helliwell P, Mease PJ, Nash P, Ritchlin C, Taylor W. Assessment of patients with psoriatic arthritis: a review of currently available measures. Arthritis Rheum 2004;50:24-35.
2. Clegg DO, Reda DJ, Mejias E, Cannon GW, Weisman MH, Taylor T, et al. Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study. Arthritis Rheum 1996;39:2013-20.
3. Van Den Bosch F, Kruithof E, Baeten D, Herssens A, de Keyser F, Mielants H, et al. Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy. Arthritis Rheum 2002;46:755-65.
4. Dougodos M, Gueguen A, Nakache JP, Nguyen M, Mery C, Amor B. Evaluation of a Functional index and an articular index in ankylosing spondylitis. J Rheumatol 1988;15:302-7.
5. Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994;21:2281-5.
6. Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, et al. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727- 35.
7. Agresti A. Ordinal measure of association: gamma. In: Balding D, et al. Categorical data analysis. New Jersey: Wiley and Sons, 2002:58-9.
8. Fitzmaurice TM, Laird N, Ware J. Adjusment for baseline response. In: Balding D, et al. Applied longitudinal analysis. New Jersey, USA: Wiley, 2004:122-33.
9. Verhoeven AC, Boers M, van Der Linden S. Responsiveness of trie core set, response criteria, and utilities in early rheumatoid arthritis. Ann Rheum Dis 2000;59:966-74.